Atripla
![Gilead Sciences Proceeds with $247 Million Settlement in HIV Antitrust Case Following Trial Victory](https://pharmtales.com/wp-content/uploads/2023/09/Gilead-settles-with-direct-purchasers-of-HIV-drugs-Truvada-and-Atripla-for-247M.jpg)
Gilead Sciences Proceeds with $247 Million Settlement in HIV Antitrust Case Following Trial Victory
Anika Sharma
Despite Gilead Sciences and Teva Pharmaceutical Industries emerging victorious in a high-stakes antitrust trial related to HIV drugs earlier this ...